What are Bacterial lysate immunostimulant drugs?

Bacterial lysate immunostimulant drugs are pharmacologic agents that share a common mechanism. 2 are currently marketed, with 1 more in clinical development.

What are the marketed Bacterial lysate immunostimulant drugs?

Marketed Bacterial lysate immunostimulant drugs include OM-85 BV (Broncho-Vaxom), OM-85 BV.

Bacterial lysate immunostimulant

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2 marketed 1 in Phase 3

This page covers all Bacterial lysate immunostimulant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (2)

OM-85 BV (Broncho-Vaxom) · Kecioren Education and Training Hospital · Immunology / Respiratory
OM-85 BV is an immunostimulant derived from bacterial lysates that enhances innate and adaptive immune responses to reduce respiratory tract infections.
OM-85 BV · Chinese Academy of Medical Sciences · Immunology / Infectious Disease
OM-85 BV is a bacterial lysate immunostimulant that enhances innate and adaptive immune responses to prevent respiratory tract infections.

Phase 3 pipeline (1)

Broncho-Vaxom · OM Pharma SA · Immunology / Respiratory
Broncho-Vaxom is an oral immunostimulant that enhances innate and adaptive immune responses to prevent recurrent respiratory tract infections.

Patent intelligence

bacterial lysate immunostimulant patent landscape — aggregated cliff calendar, attackable patents, originator estates